Skip to Main Content

Paper Details

Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
Neurooncol Adv
28
2022
Author NameAffiliation
Timothy F CloughesyDavid Geffen School of Medicine, University of California los angeles
Timothy F CloughesyDavid Geffen School of Medicine, University of California los angeles
Nicholas ButowskiUniversity of California san francisco
Nicholas ButowskiUniversity of California san francisco
  • 1 - 4

Datasets

Release 1.2